Wenhui Zhao
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 5
- Cancer, Hypoxia, and Metabolism 3
-
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 3
- Circular RNAs in diseases 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Cervical Cancer and HPV Research 3
- Journals
- PLoS ONE (1 paper)Journal of Agricultural and Food Chemistry (1 paper)The FASEB Journal (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Wenhui Zhao
43 papers receiving 395 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 137
- Molecular Biology 262
- Immunology 52
- Oncology 60
- Pathology and Forensic Medicine 25
Countries citing papers authored by Wenhui Zhao
This map shows the geographic impact of Wenhui Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhui Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhui Zhao more than expected).
Fields of papers citing papers by Wenhui Zhao
This network shows the impact of papers produced by Wenhui Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhui Zhao. The network helps show where Wenhui Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenhui Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 8 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 17 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 16 | |
| 13 | 2020 | 3 | |
| 14 | 2018 | 14 | |
| 15 | 2017 | 17 | |
| 16 | 2016 | 5 | |
| 17 | Positive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status in ovarian cancer. | 2016 | 2 |
| 18 | [Correlates of cognitive impairment in patients with leukoaraiosis by magnetic resonance spectroscopy]. | 2012 | 1 |
| 19 | 2011 | 6 | |
| 20 | [Relation between c-erbB1, c-erbB2, MAPK expression and resistance to tamoxifen in breast cancer cells in vitro]. | 2006 | 1 |
About Wenhui Zhao
Wenhui Zhao is a scholar working on Cancer Research, Oncology and Immunology, having authored 46 papers that have together received 401 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), Epigenetics and DNA Methylation (3 papers), Cervical Cancer and HPV Research (3 papers), Circular RNAs in diseases (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (137 citations), Molecular Biology (262 citations) and Immunology (52 citations). Wenhui Zhao has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Jing Yan, Guangzhi Li, Dongmei Zhang, Xun Zhou, Ce Zhang, Jinfeng Zhao, Dabei Tang, Miaomiao Hou, Xin Zhao and Jinfeng Zhao. Their work appears in journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.